Cannabis

Patients with kidney disease may be using cannabis recreationally or to treat symptoms without the knowledge of their health care team, according to results of a small survey of patients from a hemodialysis clinic in Canada.

Individuals who required hospital-based care for cannabis use disorder faced nearly three times the risk for premature death, results from a cohort analysis published in JAMA Network Open showed.

The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after cannabis legalization, according to a study published in JAMA Network Open.

Heavy use of cannabis recently or at any point in a person’s lifetime was tied to decreases in brain function during a working memory task, a new cross-sectional analysis showed.

Children living in homes with adults who smoked cannabis were 5 times more likely to have cannabis biomarkers in their urine compared with children in households without reported cannabis use, according to a study in JAMA Network Open.

Adults aged 18 to 49 years who used cannabis for medical reasons had higher rates of cannabis use disorder compared with adults who only used cannabis recreationally, according to a research letter published in JAMA Psychiatry.

Genetic predisposition for schizophrenia and frequent use of cannabis both independently corresponded with an increased likelihood of developing psychosis, results of a case-control study showed.

Preliminary evidence indicates that glucagon-like peptide-1 receptor agonists like Ozempic and similar weight-loss drugs may also help treat substance use disorders.

As 2024 comes to a close, Healio is pleased to present our most widely read oncology and hematology content from the past 12 months.

LOS ANGELES — Individuals with epilepsy who used marijuana had a reduced length of hospitalization as well as a higher rate of epilepsy event capturability compared with those who did not use marijuana, data show.